ERN1 and allergic disease: This study shows evidence that perturbation of the IRE1a-XBP1 pathway may interfere with normal physiological activation of Th2 and could be exploited in settings where Th2 lymphocytes are pathologic such as asthma, allergies, and eosinophilia.